{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:01:52Z","timestamp":1789624912065,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["BJZYYB-2023-55"],"award-info":[{"award-number":["BJZYYB-2023-55"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["2024-13"],"award-info":[{"award-number":["2024-13"]}],"id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.cca.2026.121314","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:52:04Z","timestamp":1788533524000},"page":"121314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of perfluoroalkyl and polyfluoroalkyl substances with polyendocrine metabolic ovarian syndrome and endocrine abnormalities: A case\u2013control study"],"prefix":"10.1016","volume":"594","author":[{"given":"Guan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjian","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121314_bb0170","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process","volume":"407","author":"Teede","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2026.121314_bb0010","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cca.2026.121314_bb0160","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2026.121314_bb0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cca.2026.121314_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fertnstert.2016.05.011","article-title":"Environmental determinants of polycystic ovary syndrome","volume":"106","author":"Merkin","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2026.121314_bb0190","article-title":"Associations between endocrine-disrupting chemical exposure and fertility outcomes: a decade of human epidemiological evidence","volume":"15","author":"Tzouma","year":"2025","journal-title":"Life (Basel)"},{"key":"10.1016\/j.cca.2026.121314_bb0050","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ijgo.70547","article-title":"FIGO committee opinion: environmental drivers of gynecologic and reproductive health","volume":"171","author":"DeNicola","year":"2025","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.cca.2026.121314_bb0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13253-014-0180-3","article-title":"Characterization of weighted quantile sum regression for highly correlated data in a risk analysis setting","volume":"20","author":"Carrico","year":"2015","journal-title":"J. Agric. Biol. Environ. Stat."},{"key":"10.1016\/j.cca.2026.121314_bb0115","doi-asserted-by":"crossref","first-page":"47004","DOI":"10.1289\/EHP5838","article-title":"A quantile-based g-computation approach to addressing the effects of exposure mixtures","volume":"128","author":"Keil","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cca.2026.121314_bb0210","doi-asserted-by":"crossref","first-page":"57001","DOI":"10.1289\/EHP11814","article-title":"Environmental exposure to emerging alternatives of per- and Polyfluoroalkyl substances and polycystic ovarian syndrome in women diagnosed with infertility: a mixture analysis","volume":"131","author":"Zhan","year":"2023","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cca.2026.121314_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105808","article-title":"The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies","volume":"207","author":"Nikolaou","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cca.2026.121314_bb0055","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1210\/jc.2018-01855","article-title":"Endocrine disruption of androgenic activity by perfluoroalkyl substances: clinical and experimental evidence","volume":"104","author":"Di Nisio","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121314_bb0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/etc.2034","article-title":"Perfluorooctane sulfonate (PFOS) affects hormone receptor activity, steroidogenesis, and expression of endocrine-related genes in vitro and in vivo","volume":"32","author":"Du","year":"2013","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.cca.2026.121314_bb0060","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/humupd\/dmaa018","article-title":"Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary","volume":"26","author":"Ding","year":"2020","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.cca.2026.121314_bb0175","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2026.121314_bb0180","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/humrep\/dead156","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"38","author":"Teede","year":"2023","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.cca.2026.121314_bb0215","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1021\/acs.est.5c12999","article-title":"Exposure to per- and Polyfluoroalkyl substances and abnormal Glycometabolism in healthy elderly: multiomics evidence from the China BAPE study","volume":"60","author":"Zhang","year":"2026","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.cca.2026.121314_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23539","article-title":"Simultaneous quantitation of four androgens and 17-hydroxyprogesterone in polycystic ovarian syndrome patients by LC-MS\/MS","volume":"34","author":"Cao","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.cca.2026.121314_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jmsacl.2023.01.006","article-title":"Clinical utility of laboratory developed mass spectrometry assays for steroid hormone testing","volume":"28","author":"French","year":"2023","journal-title":"J. Mass Spectrom. Advan. Clin. Lab"},{"key":"10.1016\/j.cca.2026.121314_bb0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jes.2018.03.016","article-title":"Association of serum levels of perfluoroalkyl substances with gestational diabetes mellitus and postpartum blood glucose","volume":"69","author":"Wang","year":"2018","journal-title":"J. Environ. Sci."},{"key":"10.1016\/j.cca.2026.121314_bb0005","first-page":"285","article-title":"PFAS analytical methods \u2013 a practical guide","author":"Ansell","year":"2025","journal-title":"J. Fluor. Chem."},{"key":"10.1016\/j.cca.2026.121314_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2022.130163","article-title":"Occurrences of legacy and emerging per- and polyfluoroalkyl substances in human milk in China: results of the third National Human Milk Survey (2017\u20132020)","volume":"443","author":"Han","year":"2023","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.cca.2026.121314_bb0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2026.121314_bb0100","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ijheh.2018.07.009","article-title":"Perfluorinated alkyl acids in the serum and follicular fluid of UK women with and without polycystic ovarian syndrome undergoing fertility treatment and associations with hormonal and metabolic parameters","volume":"221","author":"Heffernan","year":"2018","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"10.1016\/j.cca.2026.121314_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.175313","article-title":"Per- and polyfluoroalkyl substances exposure is associated with polycystic ovary syndrome risk among women attending a fertility clinic","volume":"950","author":"Zhang","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.cca.2026.121314_bb0125","article-title":"Association of emerging alternatives to per- and polyfluoroalkyl substances with polycystic ovary syndrome among Chinese women: a case-control study","volume":"16","author":"Li","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121314_bb0195","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.envpol.2019.01.039","article-title":"Perfluoroalkyl substances exposure and risk of polycystic ovarian syndrome related infertility in Chinese women","volume":"247","author":"Wang","year":"2019","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.cca.2026.121314_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1526918","article-title":"Associations of per- and polyfluoroalkyl substances in follicular fluid with polycystic ovarian syndrome in infertile women may be mediated by sex hormones","volume":"13","author":"Bian","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.cca.2026.121314_bb0040","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/humupd\/dmq061","article-title":"Environment and women\u2019s reproductive health","volume":"17","author":"Caserta","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.cca.2026.121314_bb0085","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/er.2015-1010","article-title":"EDC-2: the endocrine society\u2019s second scientific statement on endocrine-disrupting chemicals","volume":"36","author":"Gore","year":"2015","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2026.121314_bb0025","doi-asserted-by":"crossref","DOI":"10.1289\/ehp.1510569","article-title":"What can epidemiological studies tell us about the impact of chemical mixtures on human health?","volume":"124","author":"Braun","year":"2016","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cca.2026.121314_bb0165","doi-asserted-by":"crossref","DOI":"10.1289\/EHP547","article-title":"Statistical approaches for assessing health effects of environmental chemical mixtures in epidemiology: lessons from an innovative workshop","volume":"124","author":"Taylor","year":"2016","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cca.2026.121314_bb0110","doi-asserted-by":"crossref","first-page":"26408","DOI":"10.1021\/acs.est.5c13063","article-title":"Prenatal exposure to per- and polyfluoroalkyl substances and maternal thyroid function during pregnancy in a cohort with high familial likelihood of autism spectrum disorder","volume":"59","author":"Jang","year":"2025","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.cca.2026.121314_bb0045","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1021\/acs.est.6c01370","article-title":"Per- and polyfluoroalkyl substances in umbilical cord serum and key intermediate metabolites in relation to preterm birth: a multicenter case-control study","volume":"60","author":"Chen","year":"2026","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.cca.2026.121314_bb0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.yrtph.2019.05.008","article-title":"Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria","volume":"106","author":"Pizzurro","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.cca.2026.121314_bb0070","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/etc.4890","article-title":"Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research","volume":"40","author":"Fenton","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.cca.2026.121314_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.132062","article-title":"Per- and polyfluoroalkyl substances (PFAS) measured in seafood from a cross-section of retail stores in the United States","volume":"459","author":"Bedi","year":"2023","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.cca.2026.121314_bb0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","article-title":"Polycystic ovary syndrome as a metabolic disease","volume":"21","author":"Helvaci","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cca.2026.121314_bb0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41574-019-0273-8","article-title":"Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification","volume":"16","author":"La Merrill","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cca.2026.121314_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2026.127825","article-title":"Hormonal perturbations induced by multicategory endocrine-disrupting chemicals increase the risk of polycystic ovary syndrome","volume":"395","author":"Lu","year":"2026","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.cca.2026.121314_bb0150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.13075\/ijomeh.1896.02551","article-title":"Environmental exposure to selected non-persistent endocrine disrupting chemicals and polycystic ovary syndrome: a systematic review","volume":"38","author":"Ozga","year":"2025","journal-title":"Int. J. Occup. Med. Environ. Health"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:04:01Z","timestamp":1789621441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126004961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":41,"alternative-id":["S0009898126004961"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121314","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of perfluoroalkyl and polyfluoroalkyl substances with polyendocrine metabolic ovarian syndrome and endocrine abnormalities: A case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121314"}}